These factors include age (under 60 or over 60), sex, hepatitis B status (one or more than one), Child-Pugh stage (before or after BCLC stage), number of TACE treatments (one or more), RF ablation (completely or partially), and AFP levels (ng/ml) (>400–500 ng/ml). Here, AFP is linked to hepatitis B virus infection.